{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:10:08Z","timestamp":1777590608219,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jns.2017.01.042","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T15:45:57Z","timestamp":1484408757000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Combined use of dopamine transporter imaging (DAT-SPECT) and 123 I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease"],"prefix":"10.1016","volume":"375","author":[{"given":"Fumihito","family":"Yoshii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafuchi","family":"Ryo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2017.01.042_bb0010","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2967\/jnumed.112.105379","article-title":"Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update","volume":"54","author":"Tatsch","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"14","key":"10.1016\/j.jns.2017.01.042_bb0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/mds.25975","article-title":"Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts","volume":"29","author":"Kraemmer","year":"2014","journal-title":"Mov. Disord."},{"issue":"17","key":"10.1016\/j.jns.2017.01.042_bb0020","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.jns.2017.01.042_bb0025","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","article-title":"Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes","volume":"84","author":"Bajaj","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2017.01.042_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","article-title":"What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies","volume":"87","author":"Erro","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2017.01.042_bb0035","doi-asserted-by":"crossref","first-page":"S732","DOI":"10.1002\/mds.22499","article-title":"123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders","volume":"24","author":"Rascol","year":"2009","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","article-title":"FP-CIT and MIBG scintigraphy in early Parkinson's disease","volume":"20","author":"Spiegel","year":"2005","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.jns.2017.01.042_bb0050","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.22771","article-title":"Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors","volume":"24","author":"Novellino","year":"2009","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.archger.2012.05.001","article-title":"Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study","volume":"56","author":"Kim","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"2","key":"10.1016\/j.jns.2017.01.042_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?","volume":"24","author":"Treglia","year":"2014","journal-title":"J. Neuroimaging"},{"issue":"4","key":"10.1016\/j.jns.2017.01.042_bb0065","first-page":"476","article-title":"Cardiac sympathetic impairment parallels nigrostriatal degeneration in possible dementia with Lewy bodies","volume":"55","author":"Camacho","year":"2011","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","article-title":"Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease","volume":"43","author":"Shimizu","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.jns.2017.01.042_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jns.2017.01.042_bb0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the INDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2017.01.042_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs","volume":"35","author":"Booij","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"10.1016\/j.jns.2017.01.042_bb0100","first-page":"1326","article-title":"Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?","volume":"17","author":"Stefanelli","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2017.01.042_bb0105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio","volume":"33","author":"Tossici-Bolt","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.jns.2017.01.042_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/WNF.0b013e318211f945","article-title":"Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease","volume":"34","author":"Contrafatto","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12350-010-9313-4","article-title":"Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac iodine-123 MIBG imaging","volume":"18","author":"Okuda","year":"2011","journal-title":"J. Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","article-title":"Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations","volume":"21","author":"Nakajima","year":"2014","journal-title":"J. Nucl. Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2017.01.042_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12149-016-1065-z","article-title":"Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database","volume":"30","author":"Nakajima","year":"2016","journal-title":"Ann. Nucl. Med."},{"issue":"11","key":"10.1016\/j.jns.2017.01.042_bb0130","first-page":"1769","article-title":"PET measurement of cardiac and nigrostriatal denervation in parkinsonian syndromes","volume":"47","author":"Raffel","year":"2006","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.jns.2017.01.042_bb0135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12149-013-0702-z","article-title":"Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease","volume":"27","author":"Chiaravalloti","year":"2013","journal-title":"Ann. Nucl. Med."},{"issue":"4","key":"10.1016\/j.jns.2017.01.042_bb0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov. Disord."},{"issue":"18","key":"10.1016\/j.jns.2017.01.042_bb0145","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1212\/WNL.0000000000000385","article-title":"Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease","volume":"82","author":"Hong","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2017.01.042_bb0150","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","article-title":"Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov. Disord."},{"issue":"Suppl. 7","key":"10.1016\/j.jns.2017.01.042_bb0155","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10575","article-title":"DAT imaging in drug-induced and psychogenic parkinsonism","volume":"18","author":"Tolosa","year":"2003","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2017.01.042_bb0160","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00415-009-5039-0","article-title":"Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism","volume":"256","author":"Tinazzi","year":"2009","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2017.01.042_bb0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/jnnp-2012-302618","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease","volume":"84","author":"Ben\u00edtez-Rivero","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov. Disord."},{"issue":"20","key":"10.1016\/j.jns.2017.01.042_bb0175","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","article-title":"Longitudinal follow-up of SWEDD subjects in the PRECEPT study","volume":"82","author":"Marek","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2017.01.042_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.26450","article-title":"A scan without evidence is not evidence of absence: scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier","volume":"31","author":"Wile","year":"2016","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2017.01.042_bb0185","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10072-012-1244-1","article-title":"Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs","volume":"34","author":"Jang","year":"2013","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2017.01.042_bb0190","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.parkreldis.2014.09.024","article-title":"Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patients","volume":"20","author":"Yang","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.jns.2017.01.042_bb0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.parkreldis.2009.03.008","article-title":"Involvement of cardiac sympathetic nerve endings in a patient with idiopathic RBD and intact nigrostriatal pathway","volume":"15","author":"Paglionico","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.jns.2017.01.042_bb0200","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/mds.25002","article-title":"Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder","volume":"27","author":"Salsone","year":"2012","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2017.01.042_bb0205","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/ene.12444","article-title":"[123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis","volume":"21","author":"Brigo","year":"2014","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2017.01.042_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005122","article-title":"Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials","volume":"4","author":"O'Brien","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jns.2017.01.042_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","article-title":"MIBG scintigraphy in differential diagnosis of parkinsonism: a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"Clin. Auton. Res."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T18:56:20Z","timestamp":1658429780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":43,"alternative-id":["S0022510X17300436"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.042","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}